Romiplostim (Nplate)

About Kyowa Kirin

Kyowa Kirin is a leading specialty pharmaceutical company headquartered in Tokyo, Japan, with a strong focus on rare diseases and oncology. The company has built a robust pipeline through internal R&D capabilities and strategic partnerships, with particular expertise in antibody engineering and cell therapy technologies. Kyowa Kirin operates globally with a presence in Japan, Asia-Pacific, North America, and Europe, and is publicly traded on the Tokyo Stock Exchange.

Therapeutic Areas